FDA Inspection
BASF CorporationBASF Corporation – FDA Inspection, Nov 17, 2017
Record Details
This FDA Inspection record concerns BASF Corporation, with an inspection on November 17, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 7b401974-11ca-490b-9147-71fb6cd02abe
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1031534
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BASF Corporation
2| Date | Classification | Office | Project area |
|---|---|---|---|
| May 29, 2025 | VAI | New York District Office | Drug Quality Assurance |
| November 12, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BASF Corporation
- FDA Inspection 1271052 - 2025-05-29
- FDA Inspection 629448 - 2009-11-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.